ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

CEL Celadon Pharmaceuticals Plc

61.00
1.50 (2.52%)
22 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Celadon Pharmaceuticals Plc LSE:CEL London Ordinary Share GB00BDQYGP38 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  1.50 2.52% 61.00 57.00 65.00 61.00 59.50 59.50 12,246 14:00:11
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Investment Advice 149k -7.14M -0.1082 -5.64 39.26M

Celsis International - Re Directorate

28/01/2000 7:01am

UK Regulatory


RNS Number:5848E
Celsis International PLC
28 January 2000


                    APPOINTMENT OF NEW FINANCE DIRECTOR

Celsis International plc, the microbial risk management group, is pleased to
announce the appointment of Mr. Tony Rouse as Finance Director and Company
Secretary, effective from 31st January 2000.

Mr. Tony Rouse is a Chartered Accountant, was previously Finance Director of
Lucas Ingredients Limited and later Director of Mergers and Acquisitions for
that company, before becoming Finance Director of Pilgrim Food Group.

Mr. Mark Harris, who has been finance director and company secretary for the
last two years, leaves Celsis at the end of January to join a recently
established shipping business in Hong Kong.  Prior to joining Celsis Mr Harris
had spent ten years living in the Far East, and he and his family have decided
to return to Hong Kong.


Chris Evans, Chairman of Celsis, commented:

"We are grateful to Mark for the significant contribution he has made to the
development of Celsis over the last two years.  During that time, the business
has been restructured and has moved into sustained profitability.  The
business is now built on solid, profitable foundations and we wish him well in
his future career.

"I am pleased to announce the appointment of Tony Rouse who arrives at an
important stage in the development of the Company.  His many years experience
in the food industry will be invaluable to us as we seek to expand and develop
the business."


Enquiries

Celsis International plc  Chris Evans, Chairman       )
                          Jack Rowell, Chief Executive)  +44 (0) 1223 426 008

Brunswick Group Limited   James Garthwaite)
                          Juliet Marshall )              +44 (0) 171 404 5959


END


BOAILFETLAIDFII


1 Year Celadon Pharmaceuticals Chart

1 Year Celadon Pharmaceuticals Chart

1 Month Celadon Pharmaceuticals Chart

1 Month Celadon Pharmaceuticals Chart

Your Recent History

Delayed Upgrade Clock